References
- The United Nation& apos;s Children's Fund (UNICEF). Supply Annual Report 2007. Denmark: UNICEF Supply Division; 2008.
- Hersh BS, Carr RM, Fitzner J., et al Ensuring injection safety during measles immunization campaigns: More than auto-dis-able syringes and safety boxes. J Infect Dis. 2003. May 15;187 Suppl 1: S299-306.
- Simonsen L, Kane A, Lloyd J., et al Unsafe injections in the developing world and transmission of blood-borne pathogens. Bull World Health Organ. 1999; 77 (10): 789–800.
- Drucker E, Alcabes PG, Marx PA. The injection century: Mas-sive unsterile injections and the emergence of human pathogens. Lancet. 2001. Dec 8; 358 (9297): 1989-92.
- Reeler AV. Injections: A fatal attraction? Soc Sci Med. 1990; 31 (10): 1119–25.
- Murray CJ, Lopez AD. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology. 1999. Sep;10 (5) :594–605.
- Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004. Mar; 19 (1): 95-103.
- Hutin YJ, Hauri AM, Armstrong GL. Use of injections in health-care settings worldwide, 2000: literature review and regional estimates. BMJ. 2003. Nov 8;327 (7423): 1075.
- Hutin YJ, Harpaz R, Drobeniuc J., et al Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol. 1999; 28: 782–86.
- Luby SP, Qamruddin K, Shah AA., et al The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad.,Pakistan. Epidemiol Infect. 1997. Dec; 119 (3): 349-56.
- Hersh BS, Popovici F, Jezek Z., et al Risk factors for HIV infec-tion among abandoned Romanian children. AIDS. 1993. Dec; 7 (12): 1617-24.
- Abulrahi HA, Bohlega EA, Fontaine RE., et al Plasmodium fal-ciparum malaria transmitted in hospital through heparin locks. Lancet. 1997. Jan 4; 349 (9044): 23-5.
- Ebola haemorrhagic fever in Zaire. 1976. Bull World Health Organ. 1978; 56 (2): 271–93.
- Fisher-Hoch SP, Tomori O. Nasidi A, et al. Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor med-ical practice. BMJ. 1995. Sep 30; 311: 857-59.
- Soeters R, Aus C. Hazards of injectable therapy. Trop Doct. 1989. Jul; 19 (3): 124-6.
- Archibald LK, Ramos M, Arduino MJ., et al Enterobacter cloa-cae and Pseudomonas aeruginosa polymicrobial bloodstream infections traced to extrinsic contamination of a dextrose mul-tidose vial. J Pediatr. 1998. Nov; 133 (5): 640-4.
- Safety of Injections: WHO-UNICEF-UNFP A joint statement on the use of auto-disable syringes in immunization services. Geneva (Switzerland): World Health Organization; 2003.
- UNICEF Supply Division& apos;s unpublished data. 2008.
- Siegrist CA. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol. 2007. Jul;137 Suppl 1: S46–50.
- Sood DK, Kumar S, Singh S, Sokhey J. Adverse reactions after measles vaccination in India. Natl Med J India. 1995. Sep-Oct; 8 (5): 208-10.
- Abdul Mujeeb S, Adil MM, Altaf A., et al Recycling of injection equipment in Pakistan. Infect Control Hosp Epidemiol. 2003. Feb; 24 (2): 145-6.
- Hutin Y, Hauri A, Chiarello L., et al Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ. 2003; 81 (7): 491–500.
- Kidd-Lunggren K, Broman E, Ekvall H, Gustayson O. Nosocomial transmission of hepatitis B virus infection through multi-ple-dose vials. J Hosp Infect. 1999. Sep; 43 (1): 57-62.
- UNICEF. Programme Instruction: Introduction of 2, 5, and 10 ml reuse prevention featured (RPF) Syringes for the Reconsti-tution of Vaccines to Increase Injection Safety. New York: UNICEF; 2006.
- PATH's unpublished data. 2003.
- UNICEF, World Health Organization. Immunization Summary 2006: A statistical reference. New York: UNICEF; 2008.
- E Hoekstra, A Salovaara. Further Access to Injection Safety by Introducing Re-use Prevention Featured (RPF) Syringes for Reconstitution of Vaccines. Proceedings of Global Injection Safety and Infection Control Meeting. 2007. Oct 23-25; Geneva, Switzerland.